Manisha Shah
Medical Oncology
Credentials: · ·
History
- 1993–1996
Hematology and Medical Oncology
- 1990–1993
Internal Medicine
- 1986–1990
Doctor of Medicine
Research
Journal of Clinical Oncology · 2020 · 2,397 citations
Everolimus for advanced pancreatic neuroendocrine tumors
New England Journal of Medicine · 2011 · 2,254 citations
The Lancet Oncology · 2020 · 2,115 citations
30 papers
- MC
13 papers
11 papers
10 papers
- JS
10 papers
9 papers · 3 as a fellow
9 papers
9 papers
Grants
- 2020–2025
National Cancer Institute · R01
PI · $420.4K · Beckman Research Institute/City of Hope
- 2005–2008
Targeting RAF and VEGF Signaling in Thyroid Cancer
National Cancer Institute · R21
Contact PI · $399.8K · Ohio State University
- 1995–2005
Biologic Modifier Therapies in Aids Malignancies
National Cancer Institute · U01
Contact PI · $165.6K · Ohio State University
Clinical trials
- 2013–2017
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2012–2018
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Principal investigator · Completed · Phase 1
Manisha Shah
- 2006
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
- 2005–2009
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)